NSE · Healthcare · Drug Manufacturers - Specialty & Generic
| Document | Date |
|---|---|
| Q1 FY27 earnings call SIGACHI INDUSTRIES LIMITED – Q1 FY27 EARNINGS CALL SUMMARY HEADLINE NUMBERS • Total operating income Q1 FY27: INR 121.27 crores • EBITDA Q1: INR 16. | 2026-08-20 |
| Investor presentation · Q1 FY27 SIGACHI INDUSTRIES LTD – Q1 FY27 INVESTOR SUMMARY --- HEADLINE NUMBERS • Q1 FY27 Revenue: Rs. 1,213 Mn (down 5.38% YoY from Rs. 1,282 Mn; down 0.49 | 2026-08-13 |
| Quarterly results · Q1 FY27 SIGACHI INDUSTRIES LIMITED – Q1 FY2027 FINANCIAL SUMMARY --- HEADLINE NUMBERS • Standalone Revenue (Q1 FY2027): Rs 9,827.58 lakhs, down 11.4% YoY f | 2026-08-13 |
| Q4 FY26 earnings call SIGACHI INDUSTRIES LIMITED – Q4 FY26 EARNINGS CALL SUMMARY HEADLINE NUMBERS • Q4 FY26 Operating Income: INR 121.89 crores • Q4 FY26 EBITDA: INR 15.4 | 2026-06-05 |
| Investor presentation · Q4 FY26 SIGACHI INDUSTRIES LIMITED – Q4 FY26 INVESTOR SUMMARY HEADLINE NUMBERS • Revenue FY26: Rs. 4,778 Mn (down 4.50% YoY from Rs. 5,003 Mn in FY25) • Q4 | 2026-05-30 |
| Quarterly results · Q4 FY26 SIGACHI INDUSTRIES LIMITED – FINANCIAL SUMMARY Board Meeting: May 30, 2026 --- HEADLINE NUMBERS • Full Year Revenue (FY 2025-26): Rs 37,904.24 lakh | 2026-05-30 |
| Q3 FY26 earnings call SIGACHI INDUSTRIES LIMITED – Q3 FY26 EARNINGS SUMMARY HEADLINE NUMBERS • Q3 FY26 Operating Income: INR 117.2 crores • Q3 EBITDA: INR 5.7 crores (mar | 2026-02-20 |
| Quarterly results · Q3 FY26 SIGACHI INDUSTRIES LIMITED – FINANCIAL SUMMARY Q3 FY2026 (Quarter & Nine Months Ended December 31, 2025) --- HEADLINE NUMBERS STANDALONE BASIS (Una | 2026-02-14 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹0.10 / share ex-date Sep 16, 2025 | 2025-09-16 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Sigachi Industries Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.